Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Thymoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Radiation Pneumonitis 1Pneumonia 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1Lung Diseases, Interstitial 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colitis 1Carcinoma, Renal Cell 1Advanced Squamous Non Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

perflutren 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Observation 1Lidocaine 1Health Records, Personal 1Drug Delivery Systems 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Bronchoscopy 1Blood Pressure 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Prednisone × Thoracic × Clear all
NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended
85 enrolled
Thoracic

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡